Tag: obesity
-
Weakness in Viking Therapeutics is an Opportunity
Weakness in Viking Therapeutics (VKTX) is an opportunity. For one, its VK2735 obesity treatment is that trial results show it’s outperforming other products already on the market. As noted by Seeking Alpha, “Semaglutide (Wegovy) only showed an 8% loss after 20 weeks, while tirzepatide (Zepbound) took significantly longer to reach a larger weight loss. According…
-
A Cheaper Way to Trade Obesity Treatments
The obesity epidemic is bursting at the seams. According to the World Health Organization, obesity has tripled since 1975. More than 1.9 billion adults were overweight, as of 2016, with more than 650 million considered obese. By 2030, about 20% of the global population will be obese, according to the National Centers for Biotechnology Information. That’s not…
-
Viking Therapeutics Could See Substantial Upside this Year
Keep an eye on rebounding shares of Viking Therapeutics (VKTX). Earlier this year, the company reported that the injectable form of its obesity treatment helped patients lose up to 13.1% of their weight after 13 weeks. Then, the company said the tablet form of its treatment led to a weight loss of about 3.3% after…
-
Viking Therapeutics Could Rally Above $100 this Year
Keep an eye on rebounding shares of Viking Therapeutics (VKTX). Earlier this year, the company reported that the injectable form of its obesity treatment helped patients lose up to 13.1% of their weight after 13 weeks. Then, the company said the tablet form of its treatment led to a weight loss of about 3.3% after…
-
Eli Lilly Could Soon See US FDA Approval for Obesity Drug
Eli Lilly (LLY) could see higher highs. All as new obesity drug trial results set it up for potential US FDA approval. In fact, in recent trials, patients with Type 2 diabetes lost 15.7% of their body weight within 72 weeks, according to the company. In addition, Eli Lilly noted that “The study met both…
-
Here’s Why WW International Stock up 51% in Days
WW International (WW) is exploding, as hoped. On April 11, we noted, “Investors may want to keep an eye on WW International – formerly Weight Watchers. The stock is up 53% on a volume spike to 42.8 million shares. All after WW acquired telehealth provider, Sequence, which will also give it access to a growing…